Invasive Mucinous Adenocarcinomas with Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling.
暂无分享,去创建一个
L. Borsu | M. Ladanyi | A. Drilon | W. Travis | M. Arcila | N. Rekhtman | S. Dogan | R. Benayed | Soo-Ryum Yang | K. Tan | M. Offin | C. Leduc | Jason C. Chang | Charles Leduc
[1] L. Borsu,et al. Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes , 2021, Clinical Cancer Research.
[2] J. Heymann,et al. Synchronous Pulmonary Adenocarcinomas. , 2020, American journal of clinical pathology.
[3] Sarah H. Johnson,et al. Using genomics to differentiate multiple primaries from metastatic lung cancer. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] David R. Jones,et al. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach , 2019, Clinical Cancer Research.
[5] W. Nie,et al. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings , 2019, Cancer Imaging.
[6] L. Fournel,et al. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] M. Ladanyi,et al. High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden , 2019, Clinical Cancer Research.
[8] A. Otsuka,et al. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia. , 2018, JCO precision oncology.
[9] P. Roepman,et al. Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic Investigation. , 2018, The Journal of molecular diagnostics : JMD.
[10] Shigemi Matsumoto,et al. Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E. , 2018, The oncologist.
[11] M. Ladanyi,et al. Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers. , 2018, Cancer discovery.
[12] A. Marchevsky,et al. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases. , 2017, The Journal of molecular diagnostics : JMD.
[13] H. Shim,et al. Biology of invasive mucinous adenocarcinoma of the lung. , 2017, Translational lung cancer research.
[14] Nicolai J. Birkbak,et al. Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[15] Vamsidhar Velcheti,et al. HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo‐ and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] K. Shimizu,et al. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings , 2016, OncoTargets and therapy.
[17] B. Taylor,et al. Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. , 2017, Cancer discovery.
[18] H. Asamura,et al. Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia Pattern , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[19] Stuart J. Andrews,et al. A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma , 2016, Genome Medicine.
[20] J. Choi,et al. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] K. Nafa,et al. Locked Nucleic Acid Probes (LNA) for Enhanced Detection of Low-Level, Clinically Significant Mutations. , 2016, Methods in molecular biology.
[22] Maristela L Onozato,et al. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[24] Jingyun Shi,et al. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[25] T. Kondo,et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma. , 2015, The Annals of thoracic surgery.
[26] H. Sekhon,et al. Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma. , 2014, AJR. American journal of roentgenology.
[27] Prasad S Adusumilli,et al. Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation , 2014, The American journal of surgical pathology.
[28] W. Stringer,et al. Lepidic predominant adenocarcinoma with aerogenous spread of mucin in a young patient -- a case report. , 2014, Experimental and molecular pathology.
[29] I. Petersen,et al. CD74-NRG1 fusions in lung adenocarcinoma. , 2014, Cancer discovery.
[30] M. Ladanyi,et al. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma , 2013, Modern Pathology.
[31] M. Ladanyi,et al. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. , 2013, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[32] Michael Thomas,et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. A. McIvor,et al. Severe bronchorrhea in a patient with bronchioloalveolar carcinoma. , 2012, Chest.
[34] Zoe Wainer,et al. Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[35] Akihiko Yoshizawa,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.
[36] M. Ladanyi,et al. Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. , 2011, The Journal of molecular diagnostics : JMD.
[37] G. Rossi,et al. A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular Features, and Possible Pitfalls in Routine Practice , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[38] S. Murashima,et al. Resection of mucinous lung adenocarcinoma presenting with intractable bronchorrhea. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[39] Chris Sander,et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors , 2009, Oncogene.
[40] N. Müller,et al. Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.
[41] M. Gaeta,et al. Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study. , 2003, Lung cancer.
[42] J. Fujita,et al. Evaluation of the Clonality of Multilobar Bronchioloalveolar Carcinoma of the Lung: Case Report , 2002, American journal of clinical oncology.
[43] W. Stetler-Stevenson,et al. Comparison of Extracellular Matrix Antigens in Subtypes of Bronchioloalveolar Carcinoma and Conventional Pulmonary Adenocarcinoma: An Immunohistochemical Study , 1992, The American journal of surgical pathology.